Mkts

4D Molecular Therapeutics, Inc.

NASDAQ: FDMT
$12.48+0.23 (+1.88%)
As of Nov 9, 4:00 PM ET

Key statistics

Day range
12.1512.71
52-week range
6.9616.93
Today
Open12.42
Previous close12.48
Volume—
Valuation
Market cap676.74M
P/E ratio—
EPS (TTM)-2.76
Income & risk
Dividend / yield—
Beta2.94
Avg volume932.1K
Discussion

FDMT News

Stories mentioning FDMT from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue3,04785,09090.0015.0014.001.003.005.00
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development
Sales General & Admin
Total Operating Expenses76,66770,37561,27559,47153,63556,11851,13542,461
Operating Income (Loss)(73,620)14,715(61,185)(59,456)(53,621)(56,117)(51,132)(42,456)
Interest Income4,8644,7044,3304,8595,5826,4677,2907,548
Interest Expense
Other Expense(4.00)(22.00)(21.00)(61.00)67.00(21.00)(1.00)(45.00)
Pretax Income
Tax Provision0.000.000.000.000.000.000.000.00
Net Income (Loss)(68,760)19,397(56,876)(54,658)(47,972)(49,671)(43,843)(34,953)
Earnings Per Share (Basic)(1.01)0.33(1.01)(0.98)(0.86)(0.92)(0.79)(0.63)
Earnings Per Share (Diluted)(1.01)0.33(1.01)(0.98)(0.86)(0.92)(0.79)(0.63)
Weighted Average Shares Outstanding (Basic)68,06557,93056,12655,92755,74453,94455,55455,283
Weighted Average Shares Outstanding (Diluted)68,06557,93056,12655,92755,74453,94455,55455,283

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About FDMT

4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) is a stock listed on the Nasdaq Stock Market under the ticker symbol FDMT. It last traded at $12.48 (Nov 9, 2026, 4:00 PM ET), up 1.9% on the day. That gives 4D Molecular Therapeutics a market capitalisation of $676.7M.

Over the past 52 weeks FDMT has traded between $6.96 and $16.93.

Revenue for the quarter ended Mar 31, 2026 was $3.0M; a net loss of $68.8M. Revenue was up 21664% from $14.0K in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$3.0M-$68.8M-2256.6%
Dec 31, 2025$85.1M$19.4M22.8%
Sep 30, 2025$90.0K-$56.9M-63195.6%
Jun 30, 2025$15.0K-$54.7M-364386.7%

From 4D Molecular Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…